Intralesional anti-PD-1 therapy induced significant increases in total T cells and CD8+ T cells in the immune microenvironment of DCIS but not other immune cell populations (B cells, macrophages, Treg cells). This evidence concerns the gene CD8A and ductal breast carcinoma in situ.